rxstat › Shortages › Atorvastatin Amlodipine

Atorvastatin Amlodipine (Caduet) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Nov 8, 2026

Some Atorvastatin Amlodipine products are in shortage in Canada (3 of 23 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 8, 2026.

A combination of a statin and a blood pressure medication used to lower cholesterol and blood pressure.

Products affected
3 / 23
In shortage since
Aug 1, 2026
Est. full return
Dec 8, 2026
Reports on file
63
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
CADUET
10MG 40MG · TABLET · BGP PHARMA ULC
DIN 02273306 · since ?, est. end Dec 8, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-AMLODIPINE/ATORVASTATIN
10MG 5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362759 · since Aug 5, 2026, est. end Dec 8, 2026 · Demand increase for the drug.
Active shortage
MYLAN-AMLODIPINE/ATORVASTATIN
10MG 80MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362821 · since Aug 1, 2026, est. end Dec 8, 2026 · Demand increase for the drug.
Anticipated
MYLAN-AMLODIPINE/ATORVASTATIN
5MG 40MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362775 · Demand increase for the drug.
Anticipated
CADUET
10MG 10MG · TABLET · BGP PHARMA ULC
DIN 02273284 · Disruption of the manufacture of the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
40MG 5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362775 · ended Oct 13, 2026 · Demand increase for the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
80MG 5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362783 · ended Sep 24, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-AMLODIPINE-ATORVASTATIN
80MG 10MG · TABLET · APOTEX INC
DIN 02411342 · ended Sep 22, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
80MG 5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362783 · ended Jul 18, 2025 · Demand increase for the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
40MG 5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362775 · ended Jul 18, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
40MG 10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362813 · ended Jul 18, 2025 · Quality Hold
Resolved
CADUET
80MG 5MG · TABLET · BGP PHARMA ULC
DIN 02273276 · ended Oct 17, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Atorvastatin Amlodipine is currently affected by 3 active shortage reports filed with Health Canada by BGP PHARMA ULC, MYLAN PHARMACEUTICALS ULC.

The reported causes are: disruption of the manufacture of the drug; demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Atorvastatin Amlodipine is classified under “LIPID MODIFYING AGENTS, COMBINATIONS” (ATC C10BX).

Recent changes

Common questions

What is Atorvastatin Amlodipine used for?

A combination of a statin and a blood pressure medication used to lower cholesterol and blood pressure.

When will Atorvastatin Amlodipine be back in stock in Canada?

The latest manufacturer estimate is Dec 8, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Atorvastatin Amlodipine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.